Gene · 10538
Papers1,963
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,963
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Cytotoxic granules and effector molecules from immune cells in tuberculosis: Mechanisms of host defense and therapeutic potential. | Virulence | 2025 | 40825006 | PubTator, text mining | PubMed |
| The Streptomyces Metabolite Thiostrepton Inhibits Regulatory T Cell Differentiation and Function to Boost Antitumor Immune Responses. | Eur J Immunol | 2025 | 40820379 | PubTator, text mining | PubMed |
| Prdm12 governs an epigenetic checkpoint linking neuroimmune cross-talk to CD8+ T cell exhaustion-suppressed antitumor immunity. | Sci Adv | 2025 | 40815657 | PubTator, text mining | PubMed |
| The transcription factor BATF pioneers the differentiation program of effector CD8+ T cells through the interaction with IRF4. | Cell Rep | 2025 | 40773348 | PubTator, text mining | PubMed |
| scCOSMIX: A Mixed-Effects Framework for Differential Coexpression and Transcriptional Interactions Modeling in Single-Cell RNA-Seq. | Stat Med | 2025 | 40772737 | PubTator, text mining | PubMed |
| TOX, through a glass, darkly. | Front Immunol | 2025 | 40746547 | PubTator, text mining | PubMed |
| Enhancing the potency of CAR-T cells against solid tumors through transcription factor engineering. | JCI Insight | 2025 | 40693464 | PubTator, text mining | PubMed |
| Exploring the differential functions of circulating follicular helper T and peripheral helper T cells in rheumatoid arthritis based on metabolism patterns. | Front Immunol | 2025 | 40599793 | PubTator, text mining | PubMed |
| Identification and validation of prognostic genes associated with T-cell exhaustion and macrophage polarization in breast cancer. | Front Endocrinol (Lausanne) | 2025 | 40496561 | PubTator, text mining | PubMed |
| STAT3 Facilitates Super Enhancer Formation to Promote Fibroblast-To-Myofibroblast Differentiation by the Analysis of ATAC-Seq, RNA-Seq and ChIP-Seq. | J Cell Mol Med | 2025 | 40464702 | PubTator, text mining | PubMed |
| Enhancer-driven gene regulatory networks reveal transcription factors governing T cell adaptation and differentiation in the tumor microenvironment. | Immunity | 2025 | 40425012 | PubTator, text mining | PubMed |
| Unlocking the potential of TIGIT in enhancing therapeutic strategies for acute myeloid leukemia through combined azacitidine therapy. | NPJ Precis Oncol | 2025 | 40374899 | PubTator, text mining | PubMed |
| Gfi1 controls the formation of effector-like CD8+ T cells during chronic infection and cancer. | Nat Commun | 2025 | 40374625 | PubTator, text mining | PubMed |
| scMINER: a mutual information-based framework for clustering and hidden driver inference from single-cell transcriptomics data. | Nat Commun | 2025 | 40341143 | PubTator, text mining | PubMed |
| A KAN-based hybrid deep neural networks for accurate identification of transcription factor binding sites. | PLoS One | 2025 | 40334196 | PubTator, text mining | PubMed |
| Robust differentiation of NK cells from MSLN.CAR-IL-15-engineered human iPSCs with enhanced antitumor efficacy against solid tumors. | Sci Adv | 2025 | 40315330 | PubTator, text mining | PubMed |
| Integration of single-cell and bulk RNA sequencing identifies and validates T cell-related prognostic model in hepatocellular carcinoma. | PLoS One | 2025 | 40315269 | PubTator, text mining | PubMed |
| Molecular landscape of distinct follicular lymphoma histologic grades: insights from genomic and transcriptome analyses. | Leukemia | 2025 | 40234612 | PubTator, text mining | PubMed |
| Gene Signature-Based Prognostic Model for Acute Myeloid Leukemia: The Role of BATF, EGR1, PD-1, PD-L1, and TIM-3. | Int J Med Sci | 2025 | 40225861 | PubTator, text mining | PubMed |
Genomic and Immune Profiling of Esophageal Squamous Cell Carcinoma Undergoing Neoadjuvant Therapy Versus Upfront Surgery Identifies Novel Immunogenic Cell Death-Based Signatures for Predicting Clinical Outcomes. | MedComm (2020) | 2025 | 40182138 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10538/papers?page=5